Corcept Therapeutics Inc (CORT)
24.47
+0.50
(+2.09%)
USD |
NASDAQ |
May 07, 16:00
24.47
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 4.573M |
| March 31, 2017 | 10.11M |
| December 31, 2016 | 14.66M |
| September 30, 2016 | 18.72M |
| June 30, 2016 | 18.56M |
| March 31, 2016 | 16.32M |
| December 31, 2015 | 14.96M |
| September 30, 2015 | 13.51M |
| June 30, 2015 | 12.03M |
| March 31, 2015 | 10.66M |
| December 31, 2014 | 9.424M |
| September 30, 2014 | 8.661M |
| June 30, 2014 | 7.396M |
| March 31, 2014 | 6.896M |
| December 31, 2013 | 5.743M |
| September 30, 2013 | 4.50M |
| June 30, 2013 | 3.65M |
| March 31, 2013 | 3.90M |
| December 31, 2012 | 2.65M |
| September 30, 2012 | 30.58M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical Inc | 0.00 |
| Alnylam Pharmaceuticals Inc | 1.022B |
| Catalyst Pharmaceuticals Inc | 0.00 |
| United Therapeutics Corp | 600.00M |
| XOMA Corp | 124.06M |